STAT
JUNE 24, 2025
Childhood vaccination coverage has made leaps since 1980. That is according to a study published in The Lancet Tuesday, which found stagnation and wide variation in childhood vaccination rates since 2010. But progress has significantly slowed in the last two decades.
PharmaVoice
JULY 9, 2025
Today, we’re speaking to Simone Steiner, Transgene’s new chief technology officer, about how the company is transitioning from early- to late-stage testing and advancing its manufacturing capabilities Oncology vaccines are gaining traction in the clinic as potential game changing treatments for cancer.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharma Times
JULY 10, 2025
The results, now published in Vaccines , show that the combination was well-tolerated with no serious adverse events, and generated strong immune responses. The results, now published in Vaccines , show that the combination was well-tolerated with no serious adverse events, and generated strong immune responses.
PharmaTech
JUNE 10, 2025
s CDC Vaccine Committee Overhaul for the Pharmaceutical Industry June 10, 2025 By Christopher Cole News Article The dismissal of all 17 members of the Advisory Committee on Immunization Practices has far-reaching impacts for the industry and beyond. Kennedy Jr. Industry groups have also raised serious concerns. BIO President and CEO John F.
Pharmacy Times
JULY 16, 2025
The shift away from thimerosal may increase the use of single-dose syringes, impacting vaccination practices in various healthcare settings. ACIP's recommendations are increasingly significant for pharmacies, influencing vaccination planning, billing, and patient care activities.
Pharma Times
JULY 1, 2025
The vaccine showed a 26.6% higher relative vaccine efficacy compared with the existing option. Across all age groups, risk profiles and vaccination histories, the results were consistently strong. The severity of this past flu season underscores the need for more effective vaccines.” for A/H1N1, 22.2% for B/Victoria.
Express Pharma
JUNE 25, 2025
Bharat Biotech International (BBIL) and GSK plc have announced a joint pledge to Gavi, the Vaccine Alliance, as part of the continued global roll-out of the RTS,S malaria vaccine. The companies confirmed a phased reduction in the vaccine’s price to below USD 5 by 2028.
Expert insights. Personalized for you.
353 
Let's personalize your content